At Health Enterprise East we believe in improving healthcare through technology and innovation
The Challenge The team at DXS have developed a smart referral solution. The innovation is expected to enhance efficiencies in primary and secondary care by reducing inappropriate referrals, excessive secondary care appointments, unnecessary repeat GP consultations, and the administrative burden associated with triaging and managing incorrect referrals. Health Tech Enterprise was commissioned by Health Innovation East to support […]
The Challenge The innovators had developed a digital dietary education program, targeting adults with a BMI greater than 25. The program is accessible through a website and also on a mobile app, it offers structured meal plans to the user. Health Innovation East commissioned Health Tech Enterprise to investigate the potential cost benefit of implementing […]
The Challenge The innovators at Aker Health Tech have developed an automated, self-propelled robotic colonoscopy device, capable of performing a complete colonoscopy for the lower gastrointestinal tract. This innovation is projected to significantly reduce the duration of the colonoscopy procedure and the required staffing resources. The team needed to understand the value of the device […]
Our client has developed an innovative tumour-grading technology that has the potential to revolutionize breast cancer treatment. This technology enables the stratification of patients based on their risk of cancer recurrence, aiming to reduce the amount of unnecessary chemotherapy treatments that are delivered.
Communications between clinical and operational staff at West Suffolk Hospital (WSH) relied on the use of pagers, which has proved to be inefficient and suboptimal. Health Innovation East engaged Health Tech Enterprise (HTE) to independently evaluate the implementation and benefits of Medic Bleep, a communication tool developed to improve service efficiency and reduce delays in sharing information between clinical and operational staff.
The University of South Wales (USW) sought to commercialise a novel point of care device, developed by USW researchers, for rapidly testing COVID-19. The Brief The University was working with Public Health Wales, the University Health Board and local industry to collaboratively develop the device to meet regulatory, clinical and commercial requirements. The University required […]
The Clinical Innovators Forum is designed to provide innovators with access to specialist support and advice to help take their technology innovation projects from concept through to commercialisation.
Daiken Medical, a Japanese Medical Device Manufacturer, were seeking regulatory approval to launch one of their innovative patient-controlled analgesia (PCA) infusion pumps in Europe, with a particular focus on the UK market.
MultiplAI are developing an RNA based, liquid biopsy which screens for and predicts cardiovascular disease by assessing the presence of atherosclerotic plaques in the blood. The innovation is being developed as a service for use in screening for coronary heart disease.
Neu Health developed a digital platform for people with Parkinson’s and dementia. The innovation facilitates patient empowerment and enables clinicians to close the care management and data gap between clinic visits, as well as reduce unnecessary journeys for both patients and healthcare professionals.
Our client developed an innovative tumour-grading technology that enables the stratification of patients based on their risk of cancer recurrence, guiding the use of chemotherapy. The client sought to understand the quantitative evidence on the reduction of carbon footprint resulting from decreased patient travel and improved logistics.
UCL Partners is a leading Academic Health Science Network that focuses on driving research and innovation to improve patient care and promote better health outcomes. In 2022, they launched the first UCL Partners Innovation Fellowship Programme, which supports NHS fellows in developing digital-based health solutions.
Lucida Medical develops software based on artificial intelligence methods (machine learning and image processing) to enable radiologists to find cancer accurately, consistently, and quickly using MRI. Innovators at Lucida Medical developed Prostate Intelligence (PI™) to support the diagnosis of prostate cancer in patients.
Professor Vincent Gnanapragasam and colleagues developed the Cambridge Prostate Biopsy Device (CamPROBE®), an innovative device to safely access the prostate using fewer incisions through the perineum instead of via the transrectal route. As such, the device reduces the risk of infection.
InnoScot Health work in close partnership with NHS Scotland to support the development of innovative ideas to improve patient care. They identified the need for a value assessment tool to enable their team to evaluate early-stage innovations, identify viable opportunities and efficiently allocate resources to deliver value and improvement to the NHS.
The MedTech Navigator programme identified clinical or organisational areas of unmet needs in healthcare and provided a platform for medical technology SMEs to respond to those needs by developing innovative new products and services.
Innovators from the Department of Clinical Neurosciences at the University of Cambridge had developed a machine learning algorithm to predict the speed of progression of Alzheimer’s disease. This decision support tool would enable physicians to better manage their patients by assigning them to the most appropriate treatment pathway.
ONX is a non-invasive molecular test developed by UK based Cambridge Oncometrix. The test will enable risk-stratification and improve true positive rates within the diagnostic pathway for those with suspected prostate cancer. ONX will be conducted prior to multi-parametric magnetic resonance imaging scanning, a relatively new prostate cancer screening method. As a result, ONX will alleviate the burden placed on access to mpMRI scans.
Each year, around 2,800 people in the UK experience a hole in their upper gastrointestinal (GI) tract. The presence of a hole allows leakage of gastrointestinal contents into the body which quickly leads to infection – a serious medical emergency that can be fatal if not treated. ENDOVAC™ is a pioneering endoscopic surgical device to solve this problem.
Radiofrequency Ablation (RFA) is an established technique for the treatment of soft tissue with applications in oncology, women’s health and cardiology. RFA uses Alternating Current to generate radiofrequency (RF) energy, which when delivered to target tissues via a probe, results in localised heating and tissue destruction.
Arterial lines are frequently used in intensive care units and operating theatres to facilitate beat-to-beat monitoring of blood pressure and to allow blood sampling. The Needle-Free Arterial Non-injectable Connector (NIC) is a novel device which increases the safety of patients undergoing blood sampling.
The Brief Brush DJ was developing a state-of-the-art self-management dental app to improve oral health and make brushing your teeth fun! Brush DJ is an award-winning, free toothbrush timer app that plays 2 minutes of music taken from the user’s device to encourage brushing for an effective length of time. The app also allows users […]
A new approach to treating prominent ears, which affects 5-10% of the UK population, was developed by Dr Norbert Kang using an implant manufactured from a high technology memory metal which can be inserted subcutaneously under the skin of the ear. This quick and effective procedure performed under local anaesthetic has fewer side effects than conventional otoplasty surgery and is less invasive.
The Brief An innovation development company approached us to validate the clinical need for two innovative obstetric devices and gain additional insight from clinicians and feedback on the current market readiness for these devices. Our intervention We undertook face to face interviews with clinicians using a pre-agreed interview guide to steer the discussion and focused […]
Priority Digital Health aims to streamline and connect primary care health and wellbeing services using digital technologies to facilitate social prescribing. The company created a new digital screening and demand-management tool, priority.you which enables GP practices to triage patients into – or out of – practices safely and effectively according to need.
It is conservatively estimated that 4M temporary tracheostomies are performed throughout Europe and the US each year. The procedure involves making an incision on the anterior aspect of the neck, and opening a direct airway through an incision in the trachea. Tracheseal is a dedicated tracheostomy wound dressing to be used after the removal of the tracheostomy tube.
Regional anaesthesia is directed at a specific region of the body to allow a surgical operation or provide post-operative pain relief. SAFIRA makes regional anaesthesia a one person procedure, putting control in the hands of the anaesthesiologist.